CN105792821B - 包含1-茚满硫酰胺衍生物的疼痛治疗剂和/或预防剂 - Google Patents
包含1-茚满硫酰胺衍生物的疼痛治疗剂和/或预防剂 Download PDFInfo
- Publication number
- CN105792821B CN105792821B CN201480066081.3A CN201480066081A CN105792821B CN 105792821 B CN105792821 B CN 105792821B CN 201480066081 A CN201480066081 A CN 201480066081A CN 105792821 B CN105792821 B CN 105792821B
- Authority
- CN
- China
- Prior art keywords
- pain
- mmol
- dihydro
- inden
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- SNYNLFVNEGBTPL-UHFFFAOYSA-N Cc1c(C(C(C2)(F)F)N)c2cc(F)c1 Chemical compound Cc1c(C(C(C2)(F)F)N)c2cc(F)c1 SNYNLFVNEGBTPL-UHFFFAOYSA-N 0.000 description 1
- MCXMRLQXBJGNQO-UHFFFAOYSA-N Cc1c(C(C(C2)(F)F)O)c2ccc1 Chemical compound Cc1c(C(C(C2)(F)F)O)c2ccc1 MCXMRLQXBJGNQO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013-262743 | 2013-12-19 | ||
| JP2013262743 | 2013-12-19 | ||
| PCT/JP2014/083374 WO2015093515A1 (ja) | 2013-12-19 | 2014-12-17 | １－インダンスルファミド誘導体を含む疼痛の治療および／または予防剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105792821A CN105792821A (zh) | 2016-07-20 |
| CN105792821B true CN105792821B (zh) | 2018-05-04 |
Family
ID=53402860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480066081.3A Active CN105792821B (zh) | 2013-12-19 | 2014-12-17 | 包含1-茚满硫酰胺衍生物的疼痛治疗剂和/或预防剂 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9610262B2 (https=) |
| EP (1) | EP3085369B1 (https=) |
| JP (1) | JP6518595B2 (https=) |
| KR (1) | KR102250214B1 (https=) |
| CN (1) | CN105792821B (https=) |
| AU (1) | AU2014367781B2 (https=) |
| BR (1) | BR112016012833B1 (https=) |
| CA (1) | CA2932529C (https=) |
| ES (1) | ES2673876T3 (https=) |
| IL (1) | IL246036B (https=) |
| MX (1) | MX370898B (https=) |
| RU (1) | RU2678571C1 (https=) |
| SG (1) | SG11201604484UA (https=) |
| WO (1) | WO2015093515A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200132858A (ko) * | 2018-03-20 | 2020-11-25 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 간질 치료제 |
| TW202345782A (zh) * | 2022-04-27 | 2023-12-01 | 日商衛材R&D企管股份有限公司 | 帕金森氏症治療用醫藥組成物 |
| KR102815521B1 (ko) | 2022-11-11 | 2025-06-04 | 덕산에테르씨티 주식회사 | 내화성능 및 강도가 보강된 압력용기 |
| KR102803991B1 (ko) | 2022-11-11 | 2025-05-13 | 덕산에테르씨티 주식회사 | 내화성능 및 강도가 보강된 압력용기 |
| KR102815520B1 (ko) | 2022-11-11 | 2025-06-04 | 덕산에테르씨티 주식회사 | 내화성능 및 강도가 보강된 압력용기 |
| KR102917062B1 (ko) | 2023-11-01 | 2026-02-05 | 덕산에테르씨티 주식회사 | 압력 용기의 숄더부 보호용 커버 |
| KR102917063B1 (ko) | 2023-11-01 | 2026-02-23 | 덕산에테르씨티 주식회사 | 압력 용기의 숄더부 보호용 커버 |
| KR102917061B1 (ko) | 2023-11-01 | 2026-02-05 | 덕산에테르씨티 주식회사 | 압력 용기의 숄더부 보호용 커버 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102365265A (zh) * | 2009-04-09 | 2012-02-29 | 欧加农股份有限公司 | 2，3-二氢化茚衍生物 |
| WO2012038081A1 (de) * | 2010-09-22 | 2012-03-29 | Grünenthal GmbH | Substituierte benzamid-verbindungen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| US20070191452A1 (en) | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain |
| CL2007002994A1 (es) | 2006-10-19 | 2008-02-08 | Wyeth Corp | Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros. |
| TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類 |
| RU2508295C2 (ru) * | 2012-03-22 | 2014-02-27 | Общество с ограниченной ответственностью "Биофармокс" | Синтетические пептиды с ненаркотическим типом анальгетического действия |
| MY169073A (en) * | 2012-06-21 | 2019-02-13 | Eisai R&D Man Co Ltd | Indanesulfamide derivative |
-
2014
- 2014-12-17 AU AU2014367781A patent/AU2014367781B2/en active Active
- 2014-12-17 MX MX2016007370A patent/MX370898B/es active IP Right Grant
- 2014-12-17 CA CA2932529A patent/CA2932529C/en active Active
- 2014-12-17 ES ES14871860.4T patent/ES2673876T3/es active Active
- 2014-12-17 SG SG11201604484UA patent/SG11201604484UA/en unknown
- 2014-12-17 RU RU2016122189A patent/RU2678571C1/ru active
- 2014-12-17 WO PCT/JP2014/083374 patent/WO2015093515A1/ja not_active Ceased
- 2014-12-17 CN CN201480066081.3A patent/CN105792821B/zh active Active
- 2014-12-17 BR BR112016012833-8A patent/BR112016012833B1/pt active IP Right Grant
- 2014-12-17 KR KR1020167014850A patent/KR102250214B1/ko active Active
- 2014-12-17 EP EP14871860.4A patent/EP3085369B1/en active Active
- 2014-12-17 US US15/102,046 patent/US9610262B2/en active Active
- 2014-12-17 JP JP2015553575A patent/JP6518595B2/ja active Active
-
2016
- 2016-06-05 IL IL246036A patent/IL246036B/en active IP Right Grant
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102365265A (zh) * | 2009-04-09 | 2012-02-29 | 欧加农股份有限公司 | 2，3-二氢化茚衍生物 |
| WO2012038081A1 (de) * | 2010-09-22 | 2012-03-29 | Grünenthal GmbH | Substituierte benzamid-verbindungen |
Also Published As
| Publication number | Publication date |
|---|---|
| IL246036B (en) | 2018-11-29 |
| AU2014367781B2 (en) | 2019-07-04 |
| JPWO2015093515A1 (ja) | 2017-03-23 |
| EP3085369B1 (en) | 2018-04-04 |
| KR102250214B1 (ko) | 2021-05-07 |
| EP3085369A1 (en) | 2016-10-26 |
| US9610262B2 (en) | 2017-04-04 |
| WO2015093515A1 (ja) | 2015-06-25 |
| SG11201604484UA (en) | 2016-07-28 |
| ES2673876T3 (es) | 2018-06-26 |
| EP3085369A4 (en) | 2017-05-10 |
| RU2016122189A (ru) | 2018-01-24 |
| RU2678571C1 (ru) | 2019-01-30 |
| CN105792821A (zh) | 2016-07-20 |
| CA2932529A1 (en) | 2015-06-25 |
| US20160303058A1 (en) | 2016-10-20 |
| JP6518595B2 (ja) | 2019-05-22 |
| IL246036A0 (en) | 2016-07-31 |
| BR112016012833B1 (pt) | 2022-11-16 |
| BR112016012833A2 (https=) | 2017-08-08 |
| AU2014367781A1 (en) | 2016-06-23 |
| CA2932529C (en) | 2022-03-22 |
| MX370898B (es) | 2020-01-09 |
| KR20160106053A (ko) | 2016-09-09 |
| MX2016007370A (es) | 2016-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105792821B (zh) | 包含1-茚满硫酰胺衍生物的疼痛治疗剂和/或预防剂 | |
| JP7530390B2 (ja) | 新規ｅｇｆｒ阻害剤 | |
| EP1602369B1 (en) | Bupropion Metabolites for treating anxiety | |
| TWI676626B (zh) | 抑制瞬時受體電位ａ１離子通道 | |
| JP2004513061A (ja) | ビュープロピオン代謝物質ならびにその合成方法および使用 | |
| JP2024023383A (ja) | 社会的機能障害の治療方法 | |
| WO2016088813A1 (ja) | 新規ジアザビシクロ［２．２．２］オクタン誘導体 | |
| TWI859303B (zh) | 受體作動活性的化合物的鹽及結晶形 | |
| CN111902143B (zh) | 神经细胞内钙浓度上升抑制剂 | |
| JP2021073171A (ja) | （ｒ）−ジミラセタム（１）と（ｓ）−ジミラセタム（２）を非ラセミ比で含む相乗的組成物 | |
| JP2005075832A (ja) | 神経保護、抗うつおよび抗虚血活性を有する新規アダマンタン誘導体、およびその製造法 | |
| TWI702210B (zh) | 環狀胺衍生物之結晶及其醫藥用途 | |
| CN103002893B (zh) | 神经障碍性疼痛的治疗药或预防药 | |
| JP2008255064A (ja) | 睡眠障害予防治療剤 | |
| JP2005314347A (ja) | 疼痛抑制剤 | |
| WO2010029995A1 (ja) | 疼痛治療剤 | |
| CN100579373C (zh) | 包含鸦片样物质拮抗剂的组合物 | |
| HK40067231B (zh) | 新型egfr抑制剂 | |
| HK40067231A (zh) | 新型egfr抑制剂 | |
| CN109456259A (zh) | 酰胺类衍生物及其应用 | |
| CA3033249A1 (en) | Indazole compounds for use in tendon and/or ligament injuries | |
| HK40007807A (en) | Indazole compounds for use in tendon and/or ligament injuries |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |